Brief: Stereotaxis And Abbott Announce Global Collaboration Combining Leading Mapping And Robotic Technologies To Improve Treatment Of Abnormal Heart Rhythms
Stereotaxis Inc STXS.A :
* STEREOTAXIS AND ABBOTT ANNOUNCE GLOBAL COLLABORATION
COMBINING
LEADING MAPPING AND ROBOTIC TECHNOLOGIES TO IMPROVE TREATMENT OF
ABNORMAL HEART RHYTHMS
* STEREOTAXIS INC - INTEGRATED TECHNOLOGIES ARE CLEARED FOR
USE IN
EUROPE WITH ADDITIONAL REGULATORY CLEARANCES EXPECTED IN COMING
MONTHS
Source text for Eikon: ID:nGNXbC4cYB
Further company coverage: STXS.A
Recent news on Stereotaxis
See all newsStereotaxis Q2 revenue misses estimates, dragged by system decline
Brief: Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million
Surgical robotics provider Stereotaxis' Q1 revenue misses analyst estimates
Stereotaxis rises after FDA clears new heart-procedure platform
Surgical robotics firm Stereotaxis Q4 revenue jumps